Nektar Therapeutics Earnings

The next earnings date for Nektar Therapeutics has not yet been scheduled.

Analyst Estimates of Nektar Therapeutics Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Nektar Therapeutics Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025---$0100.00%
05/07/2025Before Market$-0.24-26.53%
03/03/2025Before Market$-0.1523.08%
11/07/2024After Market$-0.1814.29%
08/08/2024After Market$-0.25-25.00%
05/09/2024After Market$-0.190.00%
03/04/2024After Market$-0.22-4.76%
11/07/2023After Market$-0.24-20.00%
08/08/2023After Market$-0.273.57%
05/09/2023After Market$-0.32-28.00%
02/28/2023After Market$-0.3228.89%
11/03/2022After Market$-0.3131.11%
08/04/2022After Market$-0.859.57%
05/05/2022After Market$-0.4927.94%
02/28/2022After Market$-0.792.47%
11/04/2021After Market$-0.7012.50%
08/05/2021After Market$-0.695.48%
05/06/2021After Market$-0.676.94%
02/25/2021After Market$-0.654.41%
11/05/2020After Market$-0.6117.57%
08/06/2020After Market$-0.4533.82%
05/07/2020After Market$-0.5331.17%
02/27/2020After Market$-0.645.88%
11/06/2019After Market$-0.5623.29%
08/08/2019After Market$-0.6321.25%
05/08/2019After Market$-0.681.45%
02/28/2019After Market$-0.5712.31%
11/07/2018After Market$-0.5611.11%
08/08/2018After Market$5.332.11%
05/10/2018After Market$-0.60-11.11%
03/01/2018After Market$-0.1168.57%
11/07/2017After Market$0.37105.56%
08/08/2017After Market$-0.360.00%
05/09/2017After Market$-0.420.00%
03/01/2017After Market$-0.28-7.69%
11/03/2016After Market$-0.328.57%
08/03/2016After Market$-0.36-9.09%
05/03/2016After Market$-0.1439.13%
03/01/2016Before Market$-0.404.76%
11/05/2015After Market$-0.0675.00%
08/05/2015After Market$-0.400.00%
04/30/2015After Market$0.25162.50%
02/24/2015After Market$-0.352.78%
11/06/2014After Market$0.5335.90%
07/31/2014---$-0.2629.73%
05/07/2014---$-0.37-19.35%
02/26/2014---$-0.41-141.18%
11/07/2013---$-0.1436.36%
08/08/2013---$-0.3715.91%
05/09/2013---$-0.48-14.29%
02/28/2013---$-0.46-2.22%
11/09/2012---$-0.382.56%
08/09/2012---$-0.3011.76%
05/02/2012---$-0.34-3.03%
02/29/2012---$-0.3331.25%
11/02/2011---$-0.2143.24%
08/04/2011---$-0.323.03%
04/27/2011---$-0.33-22.22%
03/01/2011---$-0.1131.25%
11/04/2010---$-0.09-80.00%
07/28/2010---$-0.0187.50%
05/05/2010---$-0.0722.22%
03/02/2010---$-0.08-500.00%
11/04/2009---$-0.3313.16%
08/04/2009---$-0.3514.63%
05/06/2009---$-0.3417.07%
02/24/2009---$-0.45-45.16%
11/06/2008---$-0.40-37.93%
08/06/2008---$-0.36-16.13%
05/07/2008---$-0.44-76.00%
02/27/2008---$-0.1152.17%
11/07/2007---$-0.2033.33%
08/08/2007---$-0.300.00%
05/09/2007---$-0.2817.65%
02/28/2007---$-0.375.13%
11/02/2006---$-0.1948.65%
08/03/2006---$-0.348.11%
05/10/2006---$-0.3315.38%
02/28/2006---$-0.40-5.26%
11/03/2005---$-0.2824.32%
08/04/2005---$-0.325.88%
05/09/2005---$-0.31-6.90%
03/01/2005---$-0.2314.81%
11/03/2004---$-0.247.69%
08/02/2004---$-0.273.57%
05/05/2004---$-0.2925.64%
02/02/2004---$-0.3820.83%
11/05/2003---$-0.3140.38%
08/06/2003---$-0.2350.00%
04/22/2003---$-0.3616.28%
01/28/2003---$-0.511.92%
10/22/2002---$-0.484.00%
07/23/2002---$-0.444.35%
05/02/2002---$-0.45-2.27%
01/23/2002---$-0.370.00%
10/24/2001---$-0.335.71%
08/08/2001---$-0.345.56%
05/01/2001---$-0.3011.76%
01/24/2001---$-0.316.06%
10/23/2000---$-0.29-7.41%
07/19/2000---$-0.283.45%
04/19/2000---$-0.283.45%
01/26/2000---$-0.30-3.45%
10/25/1999---$-0.20-5.26%
07/22/1999---$-0.170.00%
04/21/1999---$-0.156.25%
01/26/1999---$-0.190.00%
10/22/1998Before Market$-0.160.00%
07/22/1998Before Market$-0.0935.71%
04/21/1998Before Market$-0.130.00%
01/22/1998Before Market$-0.1033.33%
10/06/1997Before Market$-0.0940.00%
07/24/1997Before Market$-0.0833.33%
04/24/1997Before Market$-0.0838.46%
01/31/1997---$-0.1412.50%
10/22/1996---$-0.1033.33%
07/24/1996---$-0.1115.38%
04/17/1996---$-0.0930.77%
01/23/1996---$-0.1138.89%
10/23/1995---$-0.0842.86%

More About Nektar Therapeutics

Website
https://www.nektar.com
Country
USA
Full Time Employees
61

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.

“Nektar Therapeutics Earnings” Can Refer to the Nektar Therapeutics Earnings Date

Some people say “Nektar Therapeutics earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Nektar Therapeutics position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Nektar Therapeutics Stock on the Earnings Date

If you own Nektar Therapeutics stock (NKTR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Nektar Therapeutics might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Nektar Therapeutics shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Nektar Therapeutics Earnings

You can contact us any time if you would like to ask questions about Nektar Therapeutics earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.